View Older Stories

Nov 26, 2025 06:00AM Datavault AI completes second tranche with Scilex for 1,237.6 Bitcoin

Nov 25, 2025 02:42PM Scilex raises $20.3 million through warrant exercise

Nov 24, 2025 06:01AM Scilex raises $20.3 million through warrant exercise agreement

Nov 17, 2025 08:10AM Datavault AI reports 148% revenue growth, raises 2026 guidance to $200M

Nov 11, 2025 08:30AM Datavault AI approves meme coin distribution to shareholders

Nov 10, 2025 04:01PM Datavault AI reports 467% revenue growth, secures $150M investment

Nov 3, 2025 08:02AM Datavault AI sets Nov 14 record date for Dream Bowl meme coin distribution

Oct 3, 2025 05:38AM Datavault AI converts $13.3 million in convertible debt

Oct 1, 2025 09:00AM Scilex completes first tranche of Oramed warrant repurchase for $13 million

Sep 26, 2025 04:12PM Datavault AI closes initial tranche of $150 million Bitcoin investment deal

Sep 26, 2025 03:59PM Scilex closes initial $150 million Bitcoin investment in Datavault AI

Sep 25, 2025 03:47PM Scilex to invest $150 million in bitcoin in Datavault AI deal

Sep 25, 2025 06:01AM Scilex completes $200 million bitcoin exchange for Semnur shares

Sep 24, 2025 10:12AM Scilex enters crypto partnership with Biconomy for treasury management

Sep 23, 2025 10:00AM Scilex agrees to exchange $200 million Semnur stock for bitcoin

Aug 13, 2025 06:01AM SEC approves registration for Denali-Semnur business combination

Jun 5, 2025 12:06PM Scilex Holding (SCLX) Announces Publication on GLOPERBA Dosing Adjustments in Peer-Review Journal

Apr 30, 2025 01:48PM Scilex Holding (SCLX) Regains Nasdaq Compliance

Apr 16, 2025 02:13PM Scilex Holding (SCLX) Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis

Apr 15, 2025 09:02AM Scilex Holding (SCLX) Announces Approval of NDS from Health Canada for ELYXYB®s Acute Treatment of Migraine With or Without Aura

Apr 11, 2025 09:27AM D. Boral Capital Downgrades Scilex Holding Co. (SCLX) to Hold

Apr 11, 2025 09:01AM Scilex Holding (SCLX) Announces 1-for-35 Reverse Stock Split

Jan 31, 2025 09:01AM Scilex Holding (SCLX) Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to

Jan 27, 2025 07:05AM D. Boral Capital Starts Scilex Holding Co. (SCLX) at Buy

Jan 22, 2025 08:01AM Scilex Holding (SCLX) Announces that the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for ELYXYB in Acute Pain Indication

Jan 21, 2025 11:50AM Scilex Holding (SCLX) Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)

Jan 21, 2025 09:46AM Scilex Holding (SCLX) Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

Jan 21, 2025 07:01AM Scilex Holding (SCLX) Announces that It Will Be Filing Today of a Supplemental New Drug Application with the FDA for ELYXYB in Acute Pain Indication

Jan 16, 2025 03:39PM Scilex Holding (SCLX) Amends its License Agreement with Romeg Therapeutics For the Worldwide Rights to Commercialize Gloperba®, an FDA-Approved Prophylactic Treatment for Painful Gout Flares in Adult

Jan 13, 2025 09:10AM Scilex Holding (SCLX) Announces Pain Medicine News Published Retrospective Claims Data on ZTlido® vs. Lidocaine 5% Patch

Dec 13, 2024 12:24PM Scilex Holding (SCLX) Closes $17M Offering

Dec 12, 2024 08:22AM Scilex Holding (SCLX) Announces $17 Million Registered Direct Offering

Dec 11, 2024 12:51PM Scilex Holding (SCLX): Scilex Bio Reports KDS2010 a Novel Oral Tablet Phase 2 Trial for Alzheimer’s Disease (AD) Currently Enrolling

Dec 10, 2024 07:06AM Scilex Holding (SCLX) announces binding term sheet to create commercial joint venture

Nov 22, 2024 06:01AM Scilex Holding (SCLX) Announces Receipt of Notice from Nasdaq

Nov 11, 2024 05:02PM Denali Capital Acquisition Corp. (DECA) Announces Extension of Deadline to Complete Business Combination

Oct 30, 2024 06:03AM Scilex Holding (SCLX) Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA

Oct 21, 2024 07:41AM H.C. Wainwright Reiterates Buy Rating on Scilex Holding Co. (SCLX)

Oct 16, 2024 07:01AM Scilex Holding's (SCLX) Board Authorized Management to Explore Ways to Maximize the Value of Scilex Pharmaceuticals

Oct 8, 2024 01:59PM Scilex Holding (SCLX) Provides Certain Preliminary Q3 Results

Oct 7, 2024 09:53AM Scilex Holding (SCLX) Signs $50M Registered Convertible Financing

Sep 26, 2024 09:01AM Scilex Holding (SCLX) Announces U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock

Sep 18, 2024 09:02AM Scilex Holding (SCLX) Announces the Continuing Support from Endeavor Distribution LLC in the Multi-Year Agreement for Scilex’s Commercial Products and the Satisfaction of FSF 33433 LLC $10 Million L

Sep 12, 2024 09:00AM Scilex Holding (SCLX) Announces It Has Received the Drug Distributor Accreditation from the National Association of Boards of Pharmacy

Aug 29, 2024 09:02AM Scilex Holding (SCLX) Announces FDA Final Approval to Precision Dosing for GLOPERBA Label

Jul 23, 2024 09:02AM Scilex Holding (SCLX) Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D

Jul 18, 2024 04:23PM Scilex Holding (SCLX) Files for 3.5M Share Offering by Selling Stockholders

Jul 2, 2024 05:16PM Scilex's (SCLX) Semnur Pharmaceuticals to Go Public via Merger with Denali Capital Acquisition Corp. (Nasdaq: DECA)

Jul 1, 2024 09:01AM Scilex Holding (SCLX) Reports Prelim June Results

Jun 14, 2024 01:43PM Scilex Holding (SCLX) Reports Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102

View Older Stories